AllianceBernstein’s OptiNose OPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-913
Closed -$16.9K 3198
2023
Q2
$16.9K Buy
+913
New +$21.6K ﹤0.01% 3159
2021
Q2
Sell
-3,253
Closed -$180K 3386
2021
Q1
$180K Sell
3,253
-134
-4% -$8.15K ﹤0.01% 3083
2020
Q4
$210K Sell
3,387
-200
-6% -$12.3K ﹤0.01% 2976
2020
Q3
$210K Sell
3,587
-100
-3% -$7.41K ﹤0.01% 2947
2020
Q2
$411K Buy
3,687
+994
+37% +$70.7K ﹤0.01% 2730
2020
Q1
$181K Buy
2,693
+573
+27% +$57.7K ﹤0.01% 2825
2019
Q4
$293K Hold
2,120
﹤0.01% 2783
2019
Q3
$223K Sell
2,120
-213
-9% -$21.3K ﹤0.01% 2906
2019
Q2
$248K Buy
2,333
+153
+7% +$20.2K ﹤0.01% 2895
2019
Q1
$337K Buy
2,180
+513
+31% +$59.5K ﹤0.01% 2702
2018
Q4
$155K Buy
1,667
+494
+42% +$70.5K ﹤0.01% 2935
2018
Q3
$219K Buy
1,173
+266
+29% +$75.8K ﹤0.01% 2965
2018
Q2
$381K Buy
+907
New +$306K ﹤0.01% 2715

Other funds holding OPTN

AllianceBernstein's OPTN Position: Q3 2023 in Review

AllianceBernstein sold out of OptiNose (OPTN) in Q3 2023, closing a stake of 913 shares — an estimated $16.9K sold.

AllianceBernstein first reported a position in OPTN in Q2 2018 and held it in 13 quarters. The position peaked at $411K in Q2 2020. 60 funds tracked by Wall St. Rank hold OPTN as of Q3 2023.

  • AllianceBernstein reported no remaining OptiNose position as of Q3 2023 after selling out during the quarter.
  • AllianceBernstein sold 913 OptiNose shares in Q3 2023, an estimated $16.9K.
  • AllianceBernstein first reported a position in OptiNose in Q2 2018 and held it in 13 quarters.
  • AllianceBernstein's OptiNose position peaked at $411K in Q2 2020.
  • 60 funds tracked by Wall St. Rank held OptiNose as of Q3 2023.

Based on AllianceBernstein's 13F filing for Q3 2023, filed 14 Nov 2023.